We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Interleukin-8 Predicts Outcomes for Pediatric Septic Shock

By HospiMedica International staff writers
Posted on 27 Aug 2008
Measurement of an immune system protein, interleukin-8 (IL-8) within 24 hours of a child being admitted to a hospital for septic shock has been shown to predict survival.

IL-8 is secreted into the blood as part of the body's immune system response, the chief defense mechanism against infection-related conditions such as septic shock. More...
Previous research has demonstrated that higher blood levels of IL-8 are associated with more severe cases of pediatric septic shock and a greater chance of death. That work also pointed to the potential value of IL-8 as an early diagnostic marker of systemic bacterial infections.

A new study by the same team reported an IL-8 blood level at or below 220 pg/ml should allow doctors to predict with 95% accuracy which of the children with septic shock can survive through conventional antibiotics and therapies for at least 28 days following admission. In addition, measuring IL-8 levels would make it possible to screen lower risk patients out of interventional clinical trials of experimental therapies.

Because the reagents to measure IL-8 are available and blood samples can readily be obtained from patients, Dr. Wong, professor of pediatrics at the University of Cincinnati College of Medicine (OH, USA), is looking to develop a point-of-care test that can be used to detect the IL-8 biomarker in septic shock patients, especially patients being considered for clinical trials.

The study was reported in the August 1, 2008, issue of the American Journal of Respiratory and Critical Care Medicine.

Related Links:
University of Cincinnati College of Medicine



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Monitor/Defibrillator
Zenix
New
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.